首页 > 最新文献

Deutsches Ärzteblatt Online最新文献

英文 中文
Lokal fortgeschrittenes Ösophaguskarzinom: Nach Radiochemotherapie Operation in der Diskussion 局部晚期食道癌:放化疗后的手术讨论
Pub Date : 2023-12-01 DOI: 10.3238/persesmo.2023.12.01.04
R. Meyer
{"title":"Lokal fortgeschrittenes Ösophaguskarzinom: Nach Radiochemotherapie Operation in der Diskussion","authors":"R. Meyer","doi":"10.3238/persesmo.2023.12.01.04","DOIUrl":"https://doi.org/10.3238/persesmo.2023.12.01.04","url":null,"abstract":"","PeriodicalId":11196,"journal":{"name":"Deutsches Ärzteblatt Online","volume":"8 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138609767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fortgeschrittene neuroendokrine Tumoren: Multikinase-Hemmer hemmt Tumorprogress für 10 Monate 晚期神经内分泌肿瘤:多激酶抑制剂可在10个月内抑制肿瘤进展
Pub Date : 2023-12-01 DOI: 10.3238/persesmo.2023.12.01.11
R. Meyer
{"title":"Fortgeschrittene neuroendokrine Tumoren: Multikinase-Hemmer hemmt Tumorprogress für 10 Monate","authors":"R. Meyer","doi":"10.3238/persesmo.2023.12.01.11","DOIUrl":"https://doi.org/10.3238/persesmo.2023.12.01.11","url":null,"abstract":"","PeriodicalId":11196,"journal":{"name":"Deutsches Ärzteblatt Online","volume":" 21","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138615598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Solide Tumoren: CAR-T-Zellen werden durch RNA-Impfstoff effektiver 实体瘤:CAR-T 细胞与 RNA 疫苗配合使用更有效
Pub Date : 2023-12-01 DOI: 10.3238/persesmo.2023.12.01.03
R. Meyer
{"title":"Solide Tumoren: CAR-T-Zellen werden durch RNA-Impfstoff effektiver","authors":"R. Meyer","doi":"10.3238/persesmo.2023.12.01.03","DOIUrl":"https://doi.org/10.3238/persesmo.2023.12.01.03","url":null,"abstract":"","PeriodicalId":11196,"journal":{"name":"Deutsches Ärzteblatt Online","volume":" 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138619858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metastasiertes Pankreaskarzinom: Nab-Paclitaxel + Gemcitabin erweist sich als überlegen 转移性胰腺癌:纳布-紫杉醇+吉西他滨疗效更佳
Pub Date : 2023-12-01 DOI: 10.3238/persesmo.2023.12.01.05
Nadine Eckert
{"title":"Metastasiertes Pankreaskarzinom: Nab-Paclitaxel + Gemcitabin erweist sich als überlegen","authors":"Nadine Eckert","doi":"10.3238/persesmo.2023.12.01.05","DOIUrl":"https://doi.org/10.3238/persesmo.2023.12.01.05","url":null,"abstract":"","PeriodicalId":11196,"journal":{"name":"Deutsches Ärzteblatt Online","volume":"107 26","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138607929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Varianten des nichtkleinzelligen Lungenkarzinoms (NSCLC): Immuntherapie an genetische Eigenschaften anpassen 非小细胞肺癌(NSCLC)的变异:根据基因特征调整免疫疗法
Pub Date : 2023-12-01 DOI: 10.3238/persesmo.2023.12.01.01
J. Gulden
{"title":"Varianten des nichtkleinzelligen Lungenkarzinoms (NSCLC): Immuntherapie an genetische Eigenschaften anpassen","authors":"J. Gulden","doi":"10.3238/persesmo.2023.12.01.01","DOIUrl":"https://doi.org/10.3238/persesmo.2023.12.01.01","url":null,"abstract":"","PeriodicalId":11196,"journal":{"name":"Deutsches Ärzteblatt Online","volume":"106 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138622525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fortgeschrittenes Urothelkarzinom: Neue Standards für die Erstlinie in Sicht 晚期尿路上皮癌:一线治疗的新标准指日可待
Pub Date : 2023-12-01 DOI: 10.3238/persesmo.2023.12.01.12
J. Gulden
{"title":"Fortgeschrittenes Urothelkarzinom: Neue Standards für die Erstlinie in Sicht","authors":"J. Gulden","doi":"10.3238/persesmo.2023.12.01.12","DOIUrl":"https://doi.org/10.3238/persesmo.2023.12.01.12","url":null,"abstract":"","PeriodicalId":11196,"journal":{"name":"Deutsches Ärzteblatt Online","volume":" May","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138610921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resezierbares Magenkarzinom: Durvalumab plus FLOT verbessert Ansprechen 可切除胃癌:杜伐单抗加FLOT可改善反应
Pub Date : 2023-12-01 DOI: 10.3238/persesmo.2023.12.01.06
Nadine Eckert
{"title":"Resezierbares Magenkarzinom: Durvalumab plus FLOT verbessert Ansprechen","authors":"Nadine Eckert","doi":"10.3238/persesmo.2023.12.01.06","DOIUrl":"https://doi.org/10.3238/persesmo.2023.12.01.06","url":null,"abstract":"","PeriodicalId":11196,"journal":{"name":"Deutsches Ärzteblatt Online","volume":" 20","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138619816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mammakarzinom: Feinstaub und CO2 sind Marker für ein erhöhtes Risiko 乳腺癌:颗粒物和二氧化碳是风险增加的标志物
Pub Date : 2023-12-01 DOI: 10.3238/persesmo.2023.12.01.16
R. Meyer
{"title":"Mammakarzinom: Feinstaub und CO2 sind Marker für ein erhöhtes Risiko","authors":"R. Meyer","doi":"10.3238/persesmo.2023.12.01.16","DOIUrl":"https://doi.org/10.3238/persesmo.2023.12.01.16","url":null,"abstract":"","PeriodicalId":11196,"journal":{"name":"Deutsches Ärzteblatt Online","volume":"121 32","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138609207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Klarzelliges Nierenzellkarzinom (ccRCC): HIF-2 α -Hemmung –αneuer Ansatz mit gutem Effekt 透明细胞肾细胞癌(ccRCC):抑制 HIF-2 α --效果良好的新方法
Pub Date : 2023-12-01 DOI: 10.3238/persesmo.2023.12.01.14
J. Gulden
{"title":"Klarzelliges Nierenzellkarzinom (ccRCC): HIF-2 α -Hemmung –αneuer Ansatz mit gutem Effekt","authors":"J. Gulden","doi":"10.3238/persesmo.2023.12.01.14","DOIUrl":"https://doi.org/10.3238/persesmo.2023.12.01.14","url":null,"abstract":"","PeriodicalId":11196,"journal":{"name":"Deutsches Ärzteblatt Online","volume":" 30","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138618309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frühes NSCLC und neoadjuvante Immuntherapie: Überlebensvorteile mit Pembrolizumab perioperativ 早期 NSCLC 和新辅助免疫疗法:围手术期使用 pembrolizumab 可提高生存率
Pub Date : 2023-12-01 DOI: 10.3238/persesmo.2023.12.01.02
Christine Willen
{"title":"Frühes NSCLC und neoadjuvante Immuntherapie: Überlebensvorteile mit Pembrolizumab perioperativ","authors":"Christine Willen","doi":"10.3238/persesmo.2023.12.01.02","DOIUrl":"https://doi.org/10.3238/persesmo.2023.12.01.02","url":null,"abstract":"","PeriodicalId":11196,"journal":{"name":"Deutsches Ärzteblatt Online","volume":"5 4p2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138621157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Deutsches Ärzteblatt Online
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1